Convalescent Plasma News and Research

RSS
Penn Medicine launches convalescent plasma therapy trial for COVID-19 patients

Penn Medicine launches convalescent plasma therapy trial for COVID-19 patients

Gold-containing drug auranofin kills 95% of SARS-CoV-2 virus in 48 hours in lab conditions

Gold-containing drug auranofin kills 95% of SARS-CoV-2 virus in 48 hours in lab conditions

Octapharma USA supports new COVID-19 clinical trial

Octapharma USA supports new COVID-19 clinical trial

FDA grants Emergency Use Authorization to Ortho’s COVID-19 total antibody test

FDA grants Emergency Use Authorization to Ortho’s COVID-19 total antibody test

A desperate scramble as COVID-19 families vie for access to plasma therapy

A desperate scramble as COVID-19 families vie for access to plasma therapy

Johns Hopkins experts create clinical guidebook for convalescent plasma therapy

Johns Hopkins experts create clinical guidebook for convalescent plasma therapy

UChicago Medicine launches clinical trial to explore plasma transfusions for COVID-19 patients

UChicago Medicine launches clinical trial to explore plasma transfusions for COVID-19 patients

Rockefeller and SNF announce $3 million expansion of partnership for COVID-19 research

Rockefeller and SNF announce $3 million expansion of partnership for COVID-19 research

Immunizing with plasma to fight against COVID-19

Immunizing with plasma to fight against COVID-19

Blood centers will collect plasma from COVID-19 survivors in bid for treatment

Blood centers will collect plasma from COVID-19 survivors in bid for treatment

FDA nod for first experimental plasma therapy for COVID-19 in the U.S.

FDA nod for first experimental plasma therapy for COVID-19 in the U.S.

Houston Methodist receives FDA approval to transfuse donated plasma into a COVID-19 patient

Houston Methodist receives FDA approval to transfuse donated plasma into a COVID-19 patient

Grifols Announces Formal Collaboration with US Government to Produce the First Treatment Specifically Targeting COVID-19

Grifols Announces Formal Collaboration with US Government to Produce the First Treatment Specifically Targeting COVID-19

Plasma from recovered patients used to treat coronavirus a valid approach, WHO says

Plasma from recovered patients used to treat coronavirus a valid approach, WHO says

New polyclonal immunotherapy successfully neutralizes Ebola virus

New polyclonal immunotherapy successfully neutralizes Ebola virus

Introduction of Ebola treatment beds reduces large number of deaths, Ebola cases in Sierra Leone

Introduction of Ebola treatment beds reduces large number of deaths, Ebola cases in Sierra Leone

American Journal of Respiratory and Critical Care Medicine publishes overview of MERS-CoV outbreak in Korea

American Journal of Respiratory and Critical Care Medicine publishes overview of MERS-CoV outbreak in Korea

Survivors of Ebola epidemic donate plasma to tackle disease outbreaks in West Africa

Survivors of Ebola epidemic donate plasma to tackle disease outbreaks in West Africa

Study provides proof of concept for developing antibodies against human pathogens

Study provides proof of concept for developing antibodies against human pathogens

Researchers to explore new treatment strategies using blood plasma from Ebola survivors

Researchers to explore new treatment strategies using blood plasma from Ebola survivors